Lupin’s ESG score rises to 76 in S&P Global ESG Ratings November 26, 2024 Global pharma major Lupin Limited (Lupin) today announced its S&P Global ESG scores have moved up to 76 from 69 last year, well above the industry average of 30 in the pharmaceuticals sector. The company has demonstrated... Trending WHO South-East Asia Region home to 480 million older people by 2050 IT industry employees on risk of developing chronic diseases: ICMR Onion Tea for Uterus Health: Myth or Miracle? Latest AIIMS Doctor perform congenital lung malformation rare surgery on 4-month child 29-year-old woman undergoes breast reconstruction for childhood burn deformity Zydus signs MoU with Apollo Hospitals for multi-cancer early detection test Why India needs uniform strategy for equitable access to Cancer treatment, experts explain
